AW

Anthony Wood

Pfizer: 21 patents #140 of 5,153Top 3%
AP Agouron Pharmaceuticals: 3 patents #89 of 327Top 30%
Overall (All Time): #174,960 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
8486992 Carboxamide derivatives as muscarinic receptor antagonists Paul Alan Glossop, Simon John Mantell, Christine WATSON 2013-07-16
8268881 Carboxamide derivatives as muscarinic receptor antagonists Paul Alan Glossop, Simon John Mantell, Christine WATSON 2012-09-18
7772223 Carboxamide derivatives as muscarinic receptor antagonists Paul Alan Glossop, Simon John Mantell, Christine WATSON 2010-08-10
7579471 Tropane derivatives useful in therapy Patricia Ann Basford, Peter Stephenson, Stefan Colin John Taylor 2009-08-25
7576097 Tropane derivatives useful in therapy Manoussos Perros, David Anthony Price, Blanda Luzia Christa Stammen 2009-08-18
7368460 Tropane derivatives useful in therapy Manoussos Perros, David Anthony Price, Blanda Luzia Christa Stammen 2008-05-06
7217714 CCR5 modulators Duncan Robert Armour, David Anthony Price, Blanda Luzia Christa Stammen, Manoussos Perros, Martin Paul Edwards 2007-05-15
7217721 Tropane derivatives useful in therapy Patricia Ann Basford, Peter Stephenson, Stefan Colin John Taylor 2007-05-15
7141585 Pyrazole derivatives Romuald CORBAU, Charles Eric Mowbray, Manoussos Perros, Paul Anthony Stupple 2006-11-28
7041667 CCR5 modulators Duncan Robert Armour, David Anthony Price, Blanda Luzia Christa Stammen, Manoussos Perros, Martin Paul Edwards 2006-05-09
6916927 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street 2005-07-12
6855724 Tropane derivatives useful in therapy Patricia Ann Basford, Peter Stephenson, Stefan Colin John Taylor 2005-02-15
6750230 Pyrazole derivatives Romuald CORBAU, Charles Eric Mowbray, Manoussos Perros, Paul Anthony Stupple 2004-06-15
6723719 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street 2004-04-20
6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street 2003-12-30
6667314 Tropane derivatives useful in therapy Manoussos Perros, David Anthony Price, Blanda Luzia Christa Stammen 2003-12-23
6656945 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction Simon F. Campbell, Alexander Roderick MacKenzie 2003-12-02
6586430 CCR5 modulators Duncan Robert Armour, David Anthony Price, Blanda Luzia Christa Stammen, Manoussos Perros, Martin Paul Edwards 2003-07-01
6458951 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street 2002-10-01
6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street 2002-06-18
6333330 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction Mark Edward Bunnage, John Paul Mathias, Graham Nigel Maw, David James Rawson, Stephen Derek Albert Street 2001-12-25
6300335 4-aminoquinazoline derivative cGMP-PDE inhibitors for the treatment of erectile dysfunction Simon F. Campbell, Alexander Roderick MacKenzie 2001-10-09
6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction Mark Edward Bunnage, John Paul Mathias, Stephen Derek Albert Street 2001-06-26
5977142 Oxa-and thia-diazole muscarinic receptor antagonists Robert J. Bass, Alexander Roderick MacKenzie 1999-11-02